{ "items": [ "\n\n
\n \n 13 May 2022\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nDr Kate Attfield awarded project funding by Connect Immune Research and The Lorna and Yuti Chernajovsky Biomedical Research Foundation.
\n \n\n\n \n 10 May 2022\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Integrative Neuroimaging\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nOxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.
\n \n\n\n \n 28 March 2022\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Integrative Neuroimaging\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nA new DPAG-led review paper, published in the journal Brain, has shown that a poorly understood region of the brain called the claustrum may play an important role in how we experience pain.
\n \n\n\n \n 7 March 2022\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe \u00a33.9M Wellcome Collaborative Award will be used to identify the drivers of pain in people living with rheumatoid arthritis.
\n \n\n\n \n 7 February 2022\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers at Oxford University have implanted a novel closed-loop research platform for investigating the role of the pedunculopontine nucleus (PPN) \u2013 a brainstem nucleus \u2013 in Parkinson\u2019s-like Multiple Systems Atrophy (MSA).
\n \n\n\n \n 19 January 2022\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Coronavirus\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers from Oxford\u2019s Nuffield Department of Clinical Neurosciences and Department of Experimental Psychology have shown that people who have had COVID but don\u2019t complain of long COVID symptoms in daily life nevertheless can show degraded attention and memory for up to six to nine months.
\n \n\n\n \n 7 January 2022\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nHuman-Centric Drug Discovery is a new Oxford University spinout company from Professor Zameel Cader's lab.
\n \n\n\n \n 5 January 2022\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nA \u00a3210,000 donation from the Alan Davidson Foundation has been made to our Department to advance our world-leading research into Motor Neuron Disease. The funding will support a project manager to deliver an innovative research project using the genetic causes of MND to develop approaches to early diagnosis.
\n \n\n\n \n 13 December 2021\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nScientists have observed the clumping of alpha-synuclein in the cerebrospinal fluid taken from people with Parkinson's. The findings offer hope that a pioneering new clinical test could be developed to diagnose Parkinson's correctly in its early stages.
\n \n\n\n \n 19 November 2021\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Coronavirus\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nIn May 2020 our researchers initiated a global project to investigate how COVID-19 has affected people with epilepsy, their carers and health care workers.
\n \n\n\n \n 11 November 2021\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n\n \n 3 November 2021\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nMembers of the European Platform for Neurodegenerative Diseases (EPND) will establish a collaborative platform for efficient sample and data sharing, linking existing European research infrastructures to accelerate the discovery of biomarkers, new diagnostics and treatments for the benefit of people with neurodegenerative diseases such as Alzheimer's and Parkinson's.
\n \n\n\n \n 27 October 2021\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Coronavirus\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nResearch reveals risks of developing neurological complications following a positive COVID-19 PCR test, or a first dose of either the Oxford-AstraZeneca or Pfizer-BioNTech COVID-19 vaccinations.
\n \n\n\n \n 26 October 2021\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n MRC BNDU\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nA major new $9 million project funded by the Aligning Science Across Parkinson\u2019s (ASAP) initiative will map the original circuits vulnerable to Parkinson\u2019s on an unprecedented scale. The project is a collaboration between core investigators Stephanie Cragg, Richard Wade-Martins, and Peter Magill at Oxford, Mark Howe at Boston University and Dinos Meletis at the Karolinska Institutet, as well as collaborators Yulong Li at Peking University and Michael Lin at Stanford University.
\n \n\n\n \n 8 October 2021\n \n
\n\n \n\n \n\n \n \n \n \n Award\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nMapping brain network activity from structural connectivity using deep learning
\n \n\n\n \n 30 September 2021\n \n
\n\n \n\n \n\n \n \n \n \n Award\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers at Oxford University have received a prestigious Wellcome Innovator Grant for investigating the role of the pedunculopontine nucleus (PPN) \u2013 a brainstem nucleus \u2013 in human consciousness.
\n \n\n\n \n 17 September 2021\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nGreater understanding of the role of lipoproteins could support screening and efforts to develop treatments.
\n \n\n\n \n 10 September 2021\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n MRC BNDU\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n\n \n 8 September 2021\n \n
\n\n \n\n \n\n \n \n \n \n Award\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nAlex is one of eight Oxford University academics who have been awarded significant financial funding from the UKRI Future Leaders Fellowships Scheme
\n \n\n\n \n 7 September 2021\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nPatients with autoantibodies which target neuronal proteins can have pain as an under-recognised clinical manifestation.
\n \n\n